Protease Nexin I Immunostaining in Alzheimer’s Disease

  • Dorrie E. Rosenblatt
  • Changiz Geula
  • Marsel-Marek Mesulam
Part of the NATO ASI Series book series (NSSA, volume 191)

Abstract

The NATO Conference which provided the impetus for this book was focused on protease and protease inhibitor activity in the nervous system. The conference covered both the Peripheral Nervous System (PNS) and the Central Nervous System (CNS) and addressed both developmental and pathological conditions. A recurrent theme throughout the conference was that of a crucial balance between proteolytic enzyme and inhibitor activity. Another theme of the conference was that of neuron-glia interaction. This chapter will report on immunohistochemical studies on Protease Nexin I (PN I), a glial-derived serine protease inhibitor with neurite promoting activity, in Alzheimer brain and will discuss the results in light of material presented at the conference.

Keywords

Sucrose EDTA Dementia Heparin Serine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R.W. Carrell, Enter a protease inhibitor. Nature 331: 478–479 (1988).CrossRefPubMedGoogle Scholar
  2. 2.
    R. Katzman, Alzheimer’s disease. N Engl J Med 314: 964–973 (1986).CrossRefPubMedGoogle Scholar
  3. 3.
    V.W. Henderson, and C.E. Finch, The neurobiology of Alzheimer’s disease. J Neurosurg 70: 335353 (1989).Google Scholar
  4. 4.
    DJ. Selkoe, Altered structural proteins in plaques and tangles: what do they tell us about the biology of Alzheimer’s disease. Neurobiol Aging 7: 425–432 (1986).CrossRefPubMedGoogle Scholar
  5. 5.
    G.G. Gleaner, and C.W. Wong, Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122: 1131–1135 (1984).CrossRefGoogle Scholar
  6. 6.
    DJ. Selkoe, Biochemistry of altered brain proteins in Alzheimer’s disease. Ann Rev Neurosci 12: 463–490 (1989).CrossRefPubMedGoogle Scholar
  7. 7.
    C.R. Abraham, D.J. Selkoe, and H. Potter, Immunochemical identification of the serine protease inhibitor alpha-l-anti-chymotrypsin in the brain amyloid deposits of Alzheimer’s disease. Cell 52: 487–501 (1988).CrossRefPubMedGoogle Scholar
  8. 8.
    N. Kitaguchi, Y. Takahashi, Y. Tokushima, et al. Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331: 530–532 (1988).CrossRefPubMedGoogle Scholar
  9. 9.
    R.E. Tanzi, A.I. McClatchey, E.D. Lamperti, et al. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 331: 528–530 (1988).CrossRefPubMedGoogle Scholar
  10. 10.
    J.B. Baker, and R.S. Gronke, Protease nexins and cellular regulation. Semin Thromb Hemost 12: 216–220 (1986).CrossRefPubMedGoogle Scholar
  11. 11.
    DJ. Knauer, JA. Thompson, and D.D. Cunningham, Protease nexins: cell-secreted proteins that mediate the binding, internalization and degradation of regulatory serine proteases. J Cell Physiol 117: 385–396 (1983).CrossRefPubMedGoogle Scholar
  12. 12.
    E.W. Howard, and DJ. Knauer, Characterization of the receptor for protease nexin-1: protease complexes on human fibroblasts. J Cell Physiol 131: 276–283 (1987).CrossRefPubMedGoogle Scholar
  13. 13.
    S. Gloor, K. Odink, and J. Guenther, et al. A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 47: 687–693 (1986).CrossRefPubMedGoogle Scholar
  14. 14.
    D.E. Rosenblatt, C.W. Cotman, M. Nieto-Sampedro, et al. Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin1. Brain Res 415: 40–48 (1987).CrossRefPubMedGoogle Scholar
  15. 15.
    DJ. Knauer, RA. Orlando, and D.E. Rosenblatt, The glioma cell-derived neurite promoting activity protein is functionally and immunologically related to human protease nexin-I. J Cell Physiol 132: 318–324 (1987).CrossRefPubMedGoogle Scholar
  16. 16.
    D. Monard, F. Solomon, M. Rentsch, and R. Gysin, Glia-induced morphological differentiation in neuroblastoma cells. Proc Nat Acad Sci USA 70: 18941897 (1973).Google Scholar
  17. 17.
    A.D. Zum, H. Nick, and D. Monard, A glia-derived nexin promotes outgrowth in cultured chick sympathetic neurons. Dev Neurosci 10: 17–24 (1988).CrossRefGoogle Scholar
  18. 18.
    J. Lindner, J. Guenther, and H. Nick, et al. Modulation of granule cell migration by a glia-derived protein. Proc Nat Acad Sci USA 83: 4568–4571 (1986).CrossRefPubMedGoogle Scholar
  19. 19.
    Y. Schurch-Rathgeb, and D. Monard, Brain development influences the appearance of glial factor-like activity in rat brain primary cultures. Nature 273: 308–309 (1978).CrossRefPubMedGoogle Scholar
  20. 20.
    L.P. Mulligan, D.E. Rosenblatt, and D. Johnson, Protease nexin I-like activity in cultured Schwann cells. SubmittedGoogle Scholar
  21. 21.
    D.E. Rosenblatt, C. Geula, M.-M. Mesulam, Protease Nexin I immunostaining in Alzheimer’s disease. Annals of Neurol. 26: 628–634 (1989).CrossRefGoogle Scholar
  22. 22.
    Z.S. Khachaturian, Diagnosis of Alzheimer’s disease. Arch Neurol 4: 1097–1105 (1985).CrossRefGoogle Scholar
  23. 23.
    H. Hjelm, K. Hjelm, and J. Sjoquist, Protein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunoabsorbent for isolation of immunoglobulins. FEBS Lett 28: 73–76 (1972).CrossRefPubMedGoogle Scholar
  24. 24.
    U. Abildgaard, M. Lie, and O.R. Odegard, Antithrombin (heparin cofactor) assay with “new” chromo-genic substrates (S-2238 and chromozym TH). Thromb Res 11: 549–553 (1977).CrossRefPubMedGoogle Scholar
  25. 25.
    LA. Sternberger, P.H. Hardy Jr, J.J. Cuculis, and H.G. Meyer, The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J. Histochem Cytochem 18: 315–346 (1970).CrossRefPubMedGoogle Scholar
  26. 26.
    D.H. Farrell, and D.D. Cunningham, Human fibroblasts accelerate the inhibition of thrombin by protease nexin. Proc Nail Acad Sci USA. 83: 6858–6862 (1986).CrossRefGoogle Scholar
  27. 27.
    D.H. Farrell, S.L. Wagner, R.H. Yuan, and D.D. Cunningham, Localization of protease nexin on the fibroblast extracellular matrix. J Cell Physiol 134: 179–188 (1988).CrossRefPubMedGoogle Scholar
  28. 28.
    A.D. Snow, MAR. Henderson, and D Nochlin et al. The presence of heparan sulfate proteoglycan in the neuritic plaques and congophilic angiopathy in Alzheimer’s disease. Am. J. Path. 133: 456462 (1988).Google Scholar
  29. 29.
    B.W. Festoff, Proteases, their inhibitors and the extracellular matrix: factors in nerve-muscle development and maintenance. Adv Exp Med Biol 209: 25–39 (1987).PubMedGoogle Scholar
  30. 30.
    S.L. Wagner, A.L. Lau, and D.D. Cunningham, Binding of protease nexin-1 to the fibroblast surface alters its target proteinase specificity. J Biol Chem: 2 64: 611–615 (1989).Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Dorrie E. Rosenblatt
    • 1
  • Changiz Geula
    • 2
  • Marsel-Marek Mesulam
    • 2
  1. 1.lnstitute of Gerontology & Div. of GeriatricsUniversity of MichiganUSA
  2. 2.Division of Neuroscience & Behavioral NeurologyHarvard Medical SchoolUSA

Personalised recommendations